GLIANIMON

This brand name is authorized in Germany

Active ingredients

The drug GLIANIMON contains one active pharmaceutical ingredient (API):

1 Benperidol
UNII 97O6X78C53 - BENPERIDOL

Benperidol is a strong dopamine receptor antagonist with weaker serotonin receptor antagonism. In high doses, it has antihistaminergic and alpha-adrenergic properties. It possesses minimal anticholinergic properties. Benperidol is a typical antipsychotic primarily used to treat hypersexuality syndromes and can be used to treat schizophrenia.

Read about Benperidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AD07 Benperidol N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AD Butyrophenone derivatives
Discover more medicines within N05AD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut fĂźr Arzneimittel und Medizinprodukte Identifier(s): 07228350

Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈